FACIT has announced the first three investments under its new Prospects Oncology Fund for proof-of-concept development of breakthrough cancer technologies. Ontario start-ups Radialis Medical of Thunder Bay, KA Imaging of Kitchener, and DNAstack of Toronto are the first to receive capital from this new fund, illustrating the strength and breadth of the cancer research network in the province. FACIT's strategy is to bridge the gap in capital and expertise often experienced by early stage companies, and better position innovations to reach patients.

X-ray technology is at the beginning of a digital revolution that will transform the Canadian healthcare system by detecting diseases, like cancer and heart disease, faster, more accurately, and with less radiation than traditional X-ray machines, allowing patients to begin treatment sooner.

A digital X-ray developed in Waterloo has better image quality and lower radiation than its older counterparts and is more affordable to manufacture.

CAAP Company: KA Imaging Receives $1M to develop low-cost lung screening

The new money from federally funded Grand Challenges Canada will help KA Imaging build a prototype and test it in the field in Zambia by the end of the year.

Kitchener startup gets $1M to develop low-cost lung screening

A startup developing a low-cost, high-resolution digital X-ray imager to detect lung disease in developing nations has received a $1-million boost.

Six Canadian Innovations Scaling Up to Improve Global Health

Six Canadian innovations showing evidence of early promise for improving
global health will “transition-to-scale” thanks to new support from Grand Challenges Canada,
funded by the Government of Canada.